Absorption, Distribution, Metabolism and Excretion of [14C] Labelled BIA 5-1058

Summary

The purpose of the study is to determine the mass balance recovery in expired air, urine and faeces after a single oral dose of 400 mg 14C-labeled BIA 5-1058; to provide plasma, urine and faecal samples for metabolite profiling and structural identification; and determine the routes and rates of elimination of \[14C\]-BIA 5-1058

Timeline

Start

2019-01-22

Primary completion

2019-05-02

Completion

2019-05-02

Drugs

Indications